阿斯利康公司完整版新冠病毒疫苗临床试验设计方案(免积分下载)

2020-09-21 MedSci原创 MedSci原创

随着疫苗临床试验进入了最关键的III临床试验,越来越多人从各方面打探该RNA疫苗临床试验的设计方案和实施进展情况。

随着疫苗临床试验进入了最关键的III临床试验,越来越多人从各方面打探该RNA疫苗临床试验的设计方案和实施进展情况。

为了获取公众和业界同行信任,阿斯利康公司分享了正在进行的新冠病毒疫苗临床试验设计全套方案和实施手册(共110页)。

从该临床试验设计方案中可以完整地了解RNA类型疫苗的研发和临床试验细节,值得业界同行阅读参考。

可以下载梅斯医学APP,登录后,进入积分商城,免积分领取学习!

链接:Moderna公司完整版新冠病毒mRNA疫苗临床试验设计方案

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1013685, encodeId=d91210136851f, content=好东西,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac45592276, createdName=ms2000000441068030, createdTime=Thu Sep 02 09:44:38 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887031, encodeId=926288e031eb, content=<a href='/topic/show?id=ea112303079' target=_blank style='color:#2F92EE;'>#临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=23030, encryptionId=ea112303079, topicName=临床试验)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 21 10:06:17 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083337, encodeId=7352208333ee2, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Mon Jan 25 09:22:03 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028578, encodeId=29e310285e810, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 21 12:22:03 CST 2020, time=2020-09-21, status=1, ipAttribution=)]
    2021-09-02 ms2000000441068030

    好东西,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1013685, encodeId=d91210136851f, content=好东西,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac45592276, createdName=ms2000000441068030, createdTime=Thu Sep 02 09:44:38 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887031, encodeId=926288e031eb, content=<a href='/topic/show?id=ea112303079' target=_blank style='color:#2F92EE;'>#临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=23030, encryptionId=ea112303079, topicName=临床试验)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 21 10:06:17 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083337, encodeId=7352208333ee2, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Mon Jan 25 09:22:03 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028578, encodeId=29e310285e810, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 21 12:22:03 CST 2020, time=2020-09-21, status=1, ipAttribution=)]
    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1013685, encodeId=d91210136851f, content=好东西,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac45592276, createdName=ms2000000441068030, createdTime=Thu Sep 02 09:44:38 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887031, encodeId=926288e031eb, content=<a href='/topic/show?id=ea112303079' target=_blank style='color:#2F92EE;'>#临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=23030, encryptionId=ea112303079, topicName=临床试验)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 21 10:06:17 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083337, encodeId=7352208333ee2, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Mon Jan 25 09:22:03 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028578, encodeId=29e310285e810, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 21 12:22:03 CST 2020, time=2020-09-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1013685, encodeId=d91210136851f, content=好东西,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cac45592276, createdName=ms2000000441068030, createdTime=Thu Sep 02 09:44:38 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887031, encodeId=926288e031eb, content=<a href='/topic/show?id=ea112303079' target=_blank style='color:#2F92EE;'>#临床试验#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=23030, encryptionId=ea112303079, topicName=临床试验)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Sep 21 10:06:17 CST 2020, time=2020-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2083337, encodeId=7352208333ee2, content=<a href='/topic/show?id=b7cce09742a' target=_blank style='color:#2F92EE;'>#病毒疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70974, encryptionId=b7cce09742a, topicName=病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc2500219, createdName=huagfeg, createdTime=Mon Jan 25 09:22:03 CST 2021, time=2021-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028578, encodeId=29e310285e810, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Sep 21 12:22:03 CST 2020, time=2020-09-21, status=1, ipAttribution=)]
    2020-09-21 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

Moderna公司完整版新冠病毒mRNA疫苗临床试验设计方案

美国疫苗明星公司Moderna,从一开始就成为“众矢之的”,他们从来没有成功研制出来过任何疫苗产品,甚至也没有向FDA提交过他们准备研发的疫苗临床试验申请(IND)。

关于公开征求《抗肿瘤药联合治疗临床试验技术指导原则》意见的通知

目前抗肿瘤药物联合开发十分活跃。合理的联合治疗可以为肿瘤患者带来更好的治疗选择,但是不恰当的联合开发将增加受试者的风险、降低临床研发效率,浪费时间、财力和医疗资源,反而阻碍了真正有效的联合治疗药物开发

反转?第一期刊纷纷痛批俄罗斯新冠疫苗存在安全隐患!

Nature、Science纷纷下场评论,这种疫苗可能没有进行大规模试验,是危险的!

陈薇团队新冠疫苗海外开展三期临床试验

为了隆重表彰在抗击新冠肺炎疫情斗争中作出杰出贡献的功勋模范人物,张伯礼、张定宇、陈薇被授予“人民英雄”国家荣誉称号。

被暂停的牛津-阿斯利康新冠疫苗临床试验将恢复

9月12日, 从牛津大学疫苗研发团队处获悉,该团队与阿斯利康合作研发的新冠疫苗将重新恢复临床试验。牛津大学疫苗团队向澎湃新闻发送邮件称,该款新冠疫苗的随机对照临床试验将在英国所有临床试验地点继续进行。